Market revenue in 2024 | USD 97.8 million |
Market revenue in 2030 | USD 202.3 million |
Growth rate | 12.9% (CAGR from 2024 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oligonucleotides, Equipment/Synthesizer, Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide synthesis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 38.24% in 2024. Horizon Databook has segmented the South Korea oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea exhibits strong potential for R&D capabilities in pharmaceutical and biopharmaceutical sectors, boosting the demand for oligonucleotide synthesis in research. Cancer research has become a national priority for the country’s government.
Furthermore, increasing R&D investments by key pharmaceutical companies in South Korea are anticipated to create a lucrative environment for market growth. For instance, in September 2023, ST Pharm announced the expansion of its oligonucleotide manufacturing capabilities and capacity.
This expansion is aimed at growing demand for oligonucleotide therapeutics, including short interfering RNA (siRNA), Antistreptolysin O (ASO), and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), and to enhance overall capabilities.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea oligonucleotide synthesis market , including forecasts for subscribers. This country databook contains high-level insights into South Korea oligonucleotide synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account